These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1718063)

  • 1. Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506.
    Markus PM; Cai X; Ming W; Demetris AJ; Fung JJ; Starzl TE
    Transplantation; 1991 Oct; 52(4):590-4. PubMed ID: 1718063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats.
    Markus PM; Cai X; Ming W; Demetris AJ; Fung JJ; Starzl TE
    Surgery; 1991 Aug; 110(2):357-63; discussion 363-4. PubMed ID: 1713358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance induction permits the development of graft-versus-host disease: donor-mediated attack following small bowel transplantation in mixed chimeras.
    Morrissey NJ; Blom D; Ryan CK; Fisher T; Bronsther O; Orloff MS
    Transpl Immunol; 1999 Mar; 7(1):19-25. PubMed ID: 10375074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of graft-versus-host disease and the induction of transplant tolerance by low-dose UV-B irradiation of BM cells combined with cyclosporine immunosuppression.
    Ohajekwe OA; Hardy MA; Oluwole SF
    Transplantation; 1995 Dec; 60(12):1510-6. PubMed ID: 8545883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both.
    Murase N; Ye Q; Nalesnik MA; Demetris AJ; Abu-Elmagd K; Reyes J; Ichikawa N; Okuda T; Fung JJ; Starzl TE
    Transplantation; 2000 Dec; 70(11):1632-41. PubMed ID: 11152226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
    Ohajekwe OA; James T; Hardy MA; Oluwole SF
    Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of graft-versus-host disease in rat small bowel transplantation by recipient pretreatment with UV-B-modulated bone marrow cells.
    Chowdhury NC; Jin MX; Oluwole SF
    Transplantation; 1993 Jun; 55(6):1229-35. PubMed ID: 8516807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model.
    Pirenne J; Benedetti E; Gruessner A; Moon C; Hakim N; Fryer JP; Troppmann C; Nakhleh RE; Gruessner RW
    Transplantation; 1996 Jun; 61(12):1685-94. PubMed ID: 8685944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
    Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
    Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506.
    Cooper MH; Markus PM; Cai X; Starzl TE; Fung JJ
    Transplant Proc; 1991 Dec; 23(6):3238-9. PubMed ID: 1721421
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression by succinylacetone. II. Prevention of graft-vs-host disease.
    Hess RA; Tschudy DP; Blaese RM
    J Immunol; 1987 Nov; 139(9):2845-9. PubMed ID: 2889780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.
    Blazar BR; Taylor PA; Fitzsimmons WE; Vallera DA
    J Immunol; 1994 Aug; 153(4):1836-46. PubMed ID: 7519216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.
    Fay JW; Wingard JR; Antin JH; Collins RH; Piñeiro LA; Blazar BR; Saral R; Bierer BE; Przepiorka D; Fitzsimmons WE; Maher RM; Weisdorf DJ
    Blood; 1996 Apr; 87(8):3514-9. PubMed ID: 8605372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of graft failure by cyclosporine in rats receiving lymphocyte-depleted MHC-mismatched bone marrow.
    Wagner JE
    Transplantation; 1992 Mar; 53(3):624-8. PubMed ID: 1549856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation.
    Koehler MT; Howrie D; Mirro J; Neudorf S; Blatt J; Corey S; Wollman M; Kelly-Ekeroth V; Reyes J
    Bone Marrow Transplant; 1995 Jun; 15(6):895-9. PubMed ID: 7581088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHD.
    Cooper MH; Patrene KD; Vecchini F; Austin CA; Markus PM; Boggs SS
    Bone Marrow Transplant; 1994 Sep; 14(3):355-62. PubMed ID: 7527689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM; Geller RB; Lin LB; Dix SP; Holland HK; Maurer D; O'Toole K; Keller J; Connaghan DG; Heffner LT; Hillyer CD; Rodey GE; Winton EF; Maher RM; Fitzsimmons WE; Wingard JR
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease.
    Miki T; Lee YH; Tandin A; Subbotin V; Goller A; Kovscek A; Fung JJ; Valdivia LA
    Xenotransplantation; 2001 Aug; 8(3):213-21. PubMed ID: 11472629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506.
    Murase N; Demetris AJ; Woo J; Tanabe M; Furuya T; Todo S; Starzl TE
    Transplantation; 1993 Jan; 55(1):1-7. PubMed ID: 7678353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.